Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 10
2004 9
2005 4
2006 18
2007 11
2008 11
2009 15
2010 15
2011 19
2012 22
2013 27
2014 29
2015 29
2016 18
2017 19
2018 22
2019 19
2020 23
Text availability
Article attribute
Article type
Publication date

Search Results

285 results
Results by year
Filters applied: . Clear all
Page 1
Pembrolizumab for Early Triple-Negative Breast Cancer.
Schmid P, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Foukakis T, Fasching PA, Cardoso F, Untch M, Jia L, Karantza V, Zhao J, Aktan G, Dent R, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2020 Feb 27;382(9):810-821. doi: 10.1056/NEJMoa1910549. N Engl J Med. 2020. PMID: 32101663 Clinical Trial.
EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma.
Yung M, Tono T, Olszewska E, Yamamoto Y, Sudhoff H, Sakagami M, Mulder J, Kojima H, İncesulu A, Trabalzini F, Özgirgin N. Yung M, et al. Among authors: yamamoto y. J Int Adv Otol. 2017 Apr;13(1):1-8. doi: 10.5152/iao.2017.3363. Epub 2017 Jan 6. J Int Adv Otol. 2017. PMID: 28059056 Free article. Review.
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
Iwata H, Masuda N, Yamamoto Y, Fujisawa T, Toyama T, Kashiwaba M, Ohtani S, Taira N, Sakai T, Hasegawa Y, Nakamura R, Akabane H, Shibahara Y, Sasano H, Yamaguchi T, Sakamaki K, Bailey H, Cherbavaz DB, Jakubowski DM, Sugiyama N, Chao C, Ohashi Y. Iwata H, et al. Among authors: yamamoto y. Breast Cancer Res Treat. 2019 Jan;173(1):123-133. doi: 10.1007/s10549-018-4964-y. Epub 2018 Sep 21. Breast Cancer Res Treat. 2019. PMID: 30242578 Free PMC article. Clinical Trial.
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.
Mukai H, Shimizu C, Masuda N, Ohtani S, Ohno S, Takahashi M, Yamamoto Y, Nishimura R, Sato N, Ohsumi S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Lu DR, Toi M. Mukai H, et al. Among authors: yamamoto y. Int J Clin Oncol. 2019 Mar;24(3):274-287. doi: 10.1007/s10147-018-1353-9. Epub 2018 Dec 4. Int J Clin Oncol. 2019. PMID: 30515674 Free PMC article. Clinical Trial.
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Colleoni M, Luo W, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Hitre E, Graas MP, Simoncini E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O'Reilly S, Di Lauro V, Gombos A, Ruhstaller T, Burstein H, Ribi K, Bernhard J, Viale G, Maibach R, Rabaglio-Poretti M, Gelber RD, Coates AS, Di Leo A, Regan MM, Goldhirsch A; SOLE Investigators. Colleoni M, et al. Lancet Oncol. 2018 Jan;19(1):127-138. doi: 10.1016/S1470-2045(17)30715-5. Epub 2017 Nov 17. Lancet Oncol. 2018. PMID: 29158011 Clinical Trial.
Making ends meet: targeted integration of DNA fragments by genome editing.
Yamamoto Y, Gerbi SA. Yamamoto Y, et al. Chromosoma. 2018 Dec;127(4):405-420. doi: 10.1007/s00412-018-0677-6. Epub 2018 Jul 12. Chromosoma. 2018. PMID: 30003320 Free PMC article. Review.
Staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society.
Tono T, Sakagami M, Kojima H, Yamamoto Y, Matsuda K, Komori M, Hato N, Morita Y, Hashimoto S. Tono T, et al. Among authors: yamamoto y. Auris Nasus Larynx. 2017 Apr;44(2):135-140. doi: 10.1016/j.anl.2016.06.012. Epub 2016 Sep 9. Auris Nasus Larynx. 2017. PMID: 27616746 Review.
Lung-resident natural killer cells control pulmonary tumor growth in mice.
Yamamoto Y, Miyazato K, Takahashi K, Yoshimura N, Tahara H, Hayakawa Y. Yamamoto Y, et al. Cancer Sci. 2018 Sep;109(9):2670-2676. doi: 10.1111/cas.13703. Epub 2018 Jul 12. Cancer Sci. 2018. PMID: 29927042 Free PMC article.
Risk Factors of Recurrence in Pediatric Congenital Cholesteatoma.
Morita Y, Takahashi K, Izumi S, Kubota Y, Ohshima S, Yamamoto Y, Takahashi S, Horii A. Morita Y, et al. Among authors: yamamoto y. Otol Neurotol. 2017 Dec;38(10):1463-1469. doi: 10.1097/MAO.0000000000001587. Otol Neurotol. 2017. PMID: 28953605
A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study.
Yamamoto Y, Iwata H, Ueno T, Taira N, Kashiwaba M, Takahashi M, Tada H, Tsugawa K, Toyama T, Niikura N, Hara F, Fujisawa T, Yoshinami T, Saji S, Takano T, Masuda N, Morita S, Toi M, Ohno S. Yamamoto Y, et al. Jpn J Clin Oncol. 2018 Sep 1;48(9):855-859. doi: 10.1093/jjco/hyy097. Jpn J Clin Oncol. 2018. PMID: 30020510 Clinical Trial.
285 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback